Shepherd Kaplan Krochuk, LLC Abb Vie Inc. Transaction History

Shepherd Kaplan Krochuk, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$144.61 - $166.54 $8,098 - $9,326	-56 Reduced 1.04%	5,348 $852,000
Q4 2022 Feb 13, 2023	SELL	$138.31 - $165.87 $17,288 - $20,733	-125 Reduced 2.26%	5,404 $873,000
Q3 2022 Nov 09, 2022	BUY	$134.21 - $153.93 $5,502 - $6,311	41 Added 0.75%	5,529 $742,000
Q2 2022 Aug 12, 2022	SELL	$137.62 - $174.96 $122,757 - $156,064	-892 Reduced 13.98%	5,488 $841,000
Q1 2022 May 06, 2022	SELL	$131.98 - $163.75 $271,482 - $336,833	-2,057 Reduced 24.38%	6,380 $1.03 Million

Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $59,408 - $75,169	553 Added 7.01%	8,437 $1.14 Million
Q3 2021 Nov 12, 2021	SELL	$106.4 - $120.78 $38,942 - $44,205	-366 Reduced 4.44%	7,884 $850,000
Q2 2021 Aug 10, 2021	BUY	$105.21 - $117.21 $26,933 - $30,005	256 Added 3.2%	8,250 $929,000
Q1 2021 May 17, 2021	BUY	$102.3 - $112.62 $817,786 - $900,284	7,994 New	7,994 $865,000
Q4 2020 Feb 12, 2021	SELL	$80.49 - $108.67 $840,154 - $1.13 Million	-10,438 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$85.91 - $100.83 $33,934 - $39,827	-395 Reduced 3.65%	10,438 $914,000
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $794,817 - $1.06 Million	10,833 New	10,833 $1.06 Million

3,653

1.24B

15.5M

11.6M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $290B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Shepherd Kaplan Krochuk, LLC, based on Form 13F filings with the SEC.

Stay updated on Shepherd Kaplan Krochuk, LLC with notifications on news.